|
|
 Cardiovascular Information - July 20, 2008
| Diabetics have the same high risk for heart attack, stroke or even cardiovascular death as people who already suffered a heart attack, researchers report. The study, published in Circulation: Journal of the American Heart Association, also revealed that diabetics are twice as likely as non-diabetics to die after a heart attack | | A 1-year-old boy from Frankfort, Kentucky might not live beyond 13 years of age. He is suffering from Hutchinson-Gilford Progeria Syndrome, a disease that accelerates the aging process when the child is 18-24 months old. Hutchinson-Gilford Progeria syndrome is an extremely rare condition in which some aspects of aging are greatly accelerated, and few affected children live past age 13. About 1 in 8 million babies are born with this condition. It is a genetic condition, but occurs sporadically and is not inherited in families | | A recent study discovered that a vegan diet - no meat, no dairy, and no gluten -- significantly decreases the risk of heart ailments, alleviating the risk for those with rheumatoid arthritis, whose arteries are blocked by the disease. Scientists from the Karolinska Institute derived their study from an experiment that involved 58 patients divided into two groups: the vegan diet group and the non-vegan diet group | | Cats reduce stress in people's life and protect their owners from having a heart attack, a study suggests. The 10-year study, done by the researchers at the Stroke Research Center at the University of Minnesota, involved 4,435 Americans, aged 30 to 75. Research shows that those who never had a cat had a 40 percent higher risk of having a heart attack and a 30 percent greater risk of death from other cardiovascular disease than compared to those who either have a cat or had cat before | | The U.S. Food and Drug Administration on Friday approved the Genentech drug Avastin for women with advanced breast cancer. By doing so, the FDA went against the recommendation of its advisory panel that judged the effectiveness of Avastin. Avastin is already approved for treating lung and colon cancer, based on findings that it slowed tumor growth but does not help in patient survival. The ruling prompted a mixed reaction from both doctors and advocates for breast-cancer patients | |
|
|